SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending amid a mixed holiday sentiment, as the community actively debates its price action in the absence of an anticipated 'Santa rally.' Bulls maintain conviction in its long-term institutional adoption and continued ETF inflows, while a vocal segment of bears expresses significant frustration over perceived market manipulation and persistent downward trends.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

The Cardano community is currently gripped by extreme bearish sentiment, with many labeling it a "scam" or "dead chain" and attributing its struggles to founder Charles Hoskinson. This widespread pessimism is fueled by significant price declines and a perceived shift in investor focus towards AI stocks, prompting intense debate over ADA's future viability in a competitive altcoin landscape.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is actively trending as it expands its anticoagulation pipeline with new acquisitions and advances its Phase 3-ready tecarfarin with an Abbott collaboration. The community is engaged in a polarized debate, highlighting the significant market opportunity for its novel therapies against persistent concerns regarding cash burn and potential dilutive financing needed for extensive clinical trials. Discussions revolve around its "Warfarin Replacement" potential and the impact of recent funding activities on the stock's trajectory.

Rithm Capital Corp. engages in the provision of real estate, credit, and financial services. It operates through the following segments: Origination and Servicing, Investment Portfolio, Residential Transitional Lending, Asset Management, and Corporate. The Origination and Servicing segment includes residential mortgage loans underlying mortgage servicing right assets as well as those sub-service for third parties. The Investment Portfolio segment consists of residential mortgage loans, SFR properties, consumer loans, Non-Agency RMBS, Excess MSRs and servicer advance investments. The Residential Transitional Lending segment competes for both experienced sponsors, including developers and investors in residential real estate, and attractive lending opportunities based on several factors. The Asset Management segment focuses on the wholly owned subsidiaries, Sculptor, and RCM Manager. The company was founded on September 26, 2011 and is headquartered in New York, NY.

Rithm Capital Corporation

Rithm Capital is trending amidst its significant acquisitions of Paramount Group's commercial real estate portfolio and the recently completed Crestline deal, expanding its asset management footprint to over $100 billion. The community is actively discussing the company's perceived undervaluation as a REIT, with many anticipating a strategic spin-off of its mortgage business to unlock shareholder value and benefit from broader interest rate shifts.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is trending due to robust demand for its AI infrastructure and networking solutions, which powered recent strong earnings and elevated financial guidance. The community is actively discussing Cisco's resurgence to price levels not seen since the dot-com era, recognizing its pivotal role as a 'AI plumbing powerhouse' providing essential secure networking for the expanding AI ecosystem.

Stellus Capital Investment Corp, a traded fund, invests in companies located in the United States with an EBITDA of USD 5 - 50 million. The fund focuses on a broad range of sectors and industries. It provides financing in the form of equity, senior secured first lien, uni tranche, split lien and second lien debt financings for buyout transactions with an investment size of USD 10 - 75 million.

Stellus Capital Investment Corp

Stellus Capital Investment Corporation

Stellus Capital Investment is trending amidst strong quarterly earnings beats and a highly anticipated shift in monetary policy, with the community actively discussing multiple analyst upgrades and the potential for significant interest rate cuts. Investors are highlighting SCM's consistent dividend, robust balance sheet, and perceived undervaluation, especially as macro-economic factors align positively for BDCs, drawing institutional interest and expectations for continued growth.

BlackRock Institutional Trust Company N.A. - iShares MSCI Japan ETF

iShares MSCI Japan ETF

The iShares MSCI Japan ETF ($EWJ) is actively trending as the market closely monitors the Bank of Japan's evolving monetary policy, including recent shifts in interest rates and yield curve control. Community discussions center on Japan's struggle with inflation, the highly volatile yen, and the potential unwinding of the "yen carry trade," which carries significant implications for global markets and Japanese asset valuations.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Cola is trending amid a leadership transition with a new CEO announced for next year, while the market anticipates margin expansion driven by easing supply chain costs and operational efficiencies following robust performance. The community widely discusses its role as a defensive asset despite a premium valuation, with some expressing frustration over recent price action and others speculating on its potential entry into emerging markets like cannabis-infused beverages.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is trending amid a powerful resurgence in M&A activity, which is significantly boosting its investment banking revenues, coupled with strategic moves into AI integration and the active ETF space. The community is actively debating the stock's impressive run to new highs, with optimism about its role in financing major tech initiatives balancing some caution around its current valuation.

Aventus Network

Aventus Network is trending amidst community excitement surrounding its recently incorporated DAO in the UAE and the rollout of Aventus Cloud for enterprise adoption. Traders are actively discussing its strong Polkadot integration and current low market capitalization, viewing it as a potentially undervalued asset poised for a significant move with increased volume. The appointment of a key strategic advisor in Dubai further underscores its strategic focus on regional growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance

Elite Pharmaceuticals delivers record second-quarter fiscal 2026 earnings as lisdexamfetamine sales surged, though margins faced competitive pressure.

The Zacks Analyst Blog Highlights Berkshire Hathaway, Toyota Motor, McDonald's, Elite Pharmaceuticals and BK Technologies

Zacks highlights Berkshire Hathaway, Toyota, McDonald's, Elite Pharma and BK Technologies as diverse plays with unique growth catalysts and risks.

Top Analyst Reports for Berkshire Hathaway, Toyota Motor & McDonald's

Analysts spotlight Berkshire, Toyota and McDonald's, highlighting growth drivers, risks and market performance in new research reports.

ELTP Stock Gains Following Q1 Earnings Showing Strong Revenue Growth

Elite Pharmaceuticals reports strong first-quarter fiscal 2026 results with rising direct sales, higher-margin products and expanding gross profit.

2 Outperform Rated Small Caps with Recent Pull-backs

ELTP and TSSI are growth stories with recent material pull-backs.

The Zacks Analyst Blog Highlights Cisco Systems, Caterpillar, Charles Schwab and Elite Pharmaceuticals

CSCO, CAT, SCHW and ELTP are driving gains with strong segment growth, strategic deals, and rising investor interest in key sectors.

Top Analyst Reports for Cisco, Caterpillar & Charles Schwab

CSCO, CAT and SCHW shares outperformed peers as analysts highlight growth drivers and risks in key business segments.

Elite Pharmaceuticals Stock Dips Despite Record FY25 Revenue Jump

ELTP posts record fiscal 2025 revenues and operating income gains, fueled by new launches and expanding generics market share.

Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the Abbreviated New Drug Applications and New Drug Applications segments. The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.

Current Price	$0.4845
Prev Close	$0.4799
Open	$0.4701
Dividend Yield	0.00%
50-Day Moving Average	$0.5657
Beta	0.41
Avg. Volume	878,996.79
PE Ratio	86.52

52-Week High	$0.8194
52-Week Low	$0.27
Market Capitalization	$520.64M
EPS (Annual)	-$0.004
Price to Book	8.44
Revenue Per Employee	$1.24M
Enterprise Value/EBITDA	N/A

ELTP
Elite Pharmaceuticals, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ELTP News

ELTPElite Pharmaceuticals, Inc.